Idarubicin-intensified haploidentical HSCT with GvHD prophylaxis of ATG and basiliximab provides comparable results to sibling donors in high-risk acute leukemia

Ruibin Zhang(Union Hospital), Cuntai Zhang(Tongji University), Y-D Wang(Union Hospital), Peiming Zheng(Chinese Academy of Sciences), Qiuling Wu(Union Hospital), Xin‐Jiang Lu(Ningbo University), Jun Fang(Union Hospital), Z-D Zhong(Union Hospital), Yong‐Ouk You(Zhaotong University), WM Li(Union Hospital)
Bone Marrow Transplantation
June 5, 2017
Cited by 29


Related Papers